Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
08/2003
08/14/2003US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
08/14/2003US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors
08/14/2003US20030153569 Novel pyrazole and pyrazoline substituted compounds
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153566 Adenosine receptor agonist
08/14/2003US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides
08/14/2003US20030153556 Anticoagulants and antiagglomerants
08/14/2003US20030153549 Clavulinic acid derivatives; antibiotics
08/14/2003US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153510 Novel compounds inhibiting factor xa activity
08/14/2003US20030153506 Anticoagulant therapy; multicompartment kits, synergistic effect using the mixtures
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153497 A polypeptides and polynucleotides encoding the polypeptides, for obesity, insulin resistance, type 2 diabetes, cachexia
08/14/2003US20030153491 Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
08/14/2003US20030153082 An isolated population of human hematopoietic cells that proliferates in culture, obtained by differentiating primate pluripotent stem (pPS) cells, and atleast 1% cells are CD45 + and population forms colonies
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/14/2003US20030152652 Use of echinacea as a hematinic agent
08/14/2003US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof
08/14/2003US20030152645 Aqueous ionic solutions and their uses in particular in ophthlamology
08/14/2003US20030152617 Capsule, tablet with enteric, protective coatings; bioavailability
08/14/2003US20030152574 Modulate nucleic acid gene expression
08/14/2003US20030152563 Administering plasminogen activator; biocompatiblity coupling to red blood carrier; drug delivery
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2475767A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475447A1 Short interfering rna molecules directed towards a tissue factor coding nucleic acid
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475277A1 Method for producing recombinant proteins in micro-organisms
08/14/2003CA2475112A1 Anti-infarction molecules
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474687A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of thereof as medicaments
08/14/2003CA2474283A1 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003CA2474027A1 Water soluble phenylglycine derivatives
08/14/2003CA2466251A1 Therapeutic use of aziridino compounds
08/13/2003EP1334983A2 Inhibitory, monoclonal antibody against the protease which activates clotting factor VII
08/13/2003EP1334730A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
08/13/2003EP1334728A2 Antithrombotic agents
08/13/2003EP1334127A1 Single-chain multimeric polypeptides
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1140943B1 Substituted pyrroloindoles
08/13/2003EP0768886B1 Endothelial lining effects and treatment of vasospastic disorders
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals
08/13/2003CN1436304A Method and apparatus for monitoring anti-platelet agent
08/13/2003CN1436196A Pyridine-2-yl-aminoalkyl carbonyl glycyl-beta-alanine and derivs. thereof
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436168A Beta-amino acid nitrile derivs.
08/13/2003CN1436083A Preparation of pathogen inactivated solution of red blood cells having reduced immunogenicity
08/13/2003CN1436047A Compositions and methods for improving vascular health
08/13/2003CN1435243A Medicine for treating functional metrorrhagia and preparing process thereof
08/13/2003CN1117569C Bicyclic fibrinogen antagonists
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/12/2003US6605742 Rheumatic diseases; antiarthritic agents; antitumor agents
08/12/2003US6605703 Deletion of the Hck binding region in the IL-6 receptor
08/12/2003US6605641 20-HETE antagonists and agonists
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605612 Cardioprotective phosohonates and malonates
08/12/2003US6605601 Hypotensive agents; cardiovascular disorders
08/12/2003US6605600 Diuretics
08/12/2003US6605593 Enhanced efficacy and reduced toxicity
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605286 Delivery of biologically active polypeptides
08/12/2003US6605277 Conformation-specific anti-von Willebrand factor antibodies
08/12/2003US6605115 Method and composition for inhibiting cardiovascular cell proliferation
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064457A1 A method for inhibiting 'melanoma inhibitory activity' mia
08/07/2003WO2003064440A1 Compounds that inhibit factor xa activity
08/07/2003WO2003064423A1 Aza-arylpiperazines
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064387A2 Substituted indoles as alpha-1 agonists
08/07/2003WO2003064378A2 Novel compounds that inhibit factor xa activity
08/07/2003WO2003063915A1 Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
08/07/2003WO2003063908A1 Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
08/07/2003WO2003063905A1 Preventives or remedies for immunological diseases
08/07/2003WO2003063891A1 Compositions and methods for modulating connexin hemichannels
08/07/2003WO2003063881A1 Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis
08/07/2003WO2003063870A1 A combination treatment for acute myocardial infarction
08/07/2003WO2003063862A1 Cotherapy with an oxazolidinone and a vitamin b
08/07/2003WO2003063846A2 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions
08/07/2003WO2003051362A3 Polymorphs of clopidogrel hydrogensulfate
1 ... 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 ... 671